![Charles Richter King](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles Richter King
No open positions remaining
Profile
Charles Richter King was Senior Vice President of Research for GenVec, Inc. until April 15, 2009.
He joined GenVec in 1998.
Previously, he was Vice President of New Product Research for GenVec and Director of Drug Discovery for Oncologix.
Dr. King directed an experienced research group at the Georgetown University Medical School's Lombardi Cancer Research Center in Washington, DC, where he served as Associate Professor with the University's Department of Biochemistry.
He received a PhD in Biochemistry from Johns Hopkins University.
Former positions of Charles Richter King
| Companies | Position | End |
|---|---|---|
| GENVEC INC | Chief Tech/Sci/R&D Officer | 2009-04-14 |
| AGENUS INC. | Director/Board Member | - |
Training of Charles Richter King
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
27
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology Develops bio-pharmaceutical products | Health Technology |
Agenus, Inc.
 Agenus, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of technologies to treat cancers and infectious diseases | Health Technology |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Charles Richter King
